FILSPARI (sparsentan)
200 mg/1 · Film-Coated Tablet
By Travere Therapeutics, Inc.
- NDC
- 68974-200
- Route
- Oral
- Therapeutic class
- Angiotensin 2 Receptor Blocker , Angiotensin 2 Type 1 Receptor Antagonists [MoA], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Endothelin Receptor Antagonist , Endothelin Receptor Antagonists [MoA], P-Glycoprotein Inhibitors [MoA]
- Marketing category
- NDA
Package sizes
- 30 TABLET, FILM COATED in 1 BOTTLE (68974-200-30)NDC 68974-200-30Available to order
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.
Related in Cardiovascular
See all →
Multivitamin with Fluoride
15 [iU]/1 / 60 mg/1 +9 · Tablet Chewable
Method Pharmaceuticals, LLC
Available to source

Multivitamin with Fluoride
15 [iU]/1 / 60 mg/1 +9 · Tablet Chewable
Method Pharmaceuticals, LLC
Available to source

Multivitamin with Fluoride
15 [iU]/1 / 60 mg/1 +9 · Tablet Chewable
Bryant Ranch Prepack
Available to source

Multivitamin with Fluoride
15 [iU]/1 / 60 mg/1 +9 · Tablet Chewable
Bryant Ranch Prepack
Available to source
